CGONCG Oncology Inc. Common stock
79.81USD-1.08%Mkt Cap: 7.07B $P/E: —3d ago
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company's product candidate is cre…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap7.07B $
Enterprise Value5.86B $
Revenue (TTM)6.23M $
Gross Profit-607.00K $
Net Income (TTM)-161.00M $
Revenue/Share0.0760 USD
Last Price79.81 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-25.69
PEG—
EV/EBITDA-23.47
EV/Revenue940.90
P/S1104.59
P/B6.66
EPS (TTM)-2.58
EPS (Forward)-3.02
52W Range
24.8598% of range80.97
52W High80.97 USD
52W Low24.85 USD
Profitability
Gross Margin-15.02%
Oper. Margin-7467.68%
EBITDA Margin0.00%
Profit Margin-3985.02%
ROE-21.39%
ROA-20.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-132.35M $
CapEx (TTM)134.00K $
FCF Margin-1825.78%
FCF Yield-1.61%
Net Debt-1.02B $
Net Debt/EBITDA4.08
Balance Sheet
Debt/Equity0.01
Current Ratio22.22
Quick Ratio21.78
Book Value/Sh11.65 USD
Cash/Share11.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)91.08 USD
Upside (mean)+14.1%
Target Range79.00 USD – 108.00 USD
$79.00+14.1% to mean$108.00
# Analysts13
Ownership
Shares Out.88.64M
Float64.73M
Insiders0.23%
Institutions113.81%
Short Interest
Short Ratio12.3d
Short % Float13.65%
Short % Out.13.41%
Shares Short11.84M
Short (prev mo.)12.07M
Technical
SMA 5070.53 (+13.2%)
SMA 20059.07 (+35.1%)
Beta0.23
S&P 52W Chg18.16%
Avg Vol (30d)820.95K
Avg Vol (10d)737.83K
Technical Indicators
RSI (14)63.3
MACD2.3794
MACD Signal1.9094
MACD Hist.+0.4699
BB Upper80.75 USD
BB Middle74.04 USD
BB Lower67.33 USD
BB Width18.13%
ATR (14)3.401 USD
Vol Ratio (20d)0.82x